E15-26: Drug Quality Fundamentals Part I & II

 E15-26: One-Day Course, Tuesday, November 17

Dr. Michael W. Dong, MWD Consulting,  Foster City, CA

This is a combination of the two half-day courses; which is offered at a discount if taken as a one-day course. This introductory course provides a high-level overview of the entire drug development process for new therapeutics targeting human diseases, with a focus on the pivotal role of the analytical chemist in this complex, costly and multidisciplinary process.  The focus of the course is on new drug discovery and development process of small molecule innovative drugs.  See full descriptions under the half-day courses.

This course will benefit scientists currently working in the biopharmaceutical industry who want to improve their understanding of the drug discovery and development process (including pharma trends and perspectives, drug discovery, pre-clinical and clinical development, and regulations). This course is also useful for non-pharma scientists, including instrumentation specialists, who are seeking a better technical understanding of the challenges and opportunities in the industry. It is highly recommended that you have some fundamental understanding of biology, chemistry or biochemistry.

See the topics listed under each half-day course.

Dr. Michael W. Dong is aprincipal in MWD Consulting focusing on consulting and training services on HPLC/UHPLC, pharmaceutical analysis and drug quality.  He was formerly Senior Scientist in Analytical Chemistry and Quality Control of Small Molecule Pharm. Sci. at Genentech, Research Director at Synomics Pharma, Research Fellow at Purdue Pharma, and Senior Staff Scientist at Applied Biosystems / Perkin-Elmer.  He holds a Ph.D. in Analytical Chemistry from City University of New York, and a certificate in Biotechnology at U. California. Santa Cruz. He has 100+ publications and three books including a bestseller in HPLC (Modern HPLC for Practicing Scientists). He is an editorial advisory board member of LCGC magazine and American Pharmaceutical Review.